⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

IBRX

ImmunityBio, Inc.

Healthcare · Biotechnology

8.22USD

-0.0900 (-1.08%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on IBRX.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 8.22
P/E—
Dvd Ind Yld0.0%
P/B—
P/S52.5
Curr EV/T12M EBITDA-40.7
Mkt Cap (USD)8.7B
Curr EV (USD)9.6B
2)

Per Share Data

EPS T12M-0.98
DPS—
Bk Val Per Sh-0.99
Rev/Sh0.16
Cash/Sh0.34
Curr Shares Out1,059.8M
FCF/Sh-0.27
3)

Cash Flow Analysis

P/CF-31.0
Curr P/FCF-30.2
CF/NI0.3
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-169.6%
Eff Interest Rate6887.6%
4)

Growth Potential

Dil EPS 1Y Gr38.7%
Cap 1Y Gr-2.2%
BPS 1Y Gr22.1%
R&D To Sales114.7%
Retention Rate—
Rev 1Y Gr668.3%
FCF 1Y Gr22.4%
Assets 1Y Gr31.1%
5)

Profitability

EBITDA-0.2B
EBIT-0.3B
Operating Margin-151.9%
Pretax Margin-598.7%
Net Margin-598.6%
ROA-192.6%
ROE122.7%
ROC-138.5%
Asset Turnover0.32
6)

Structure

Current Ratio5.72
Quick Ratio5.36
Debt/Assets195.4%
Debt/Com Eq-117.4%
Net Debt/EBITDA-4.89
Tot Debt/Capital675.8%
Gross Margin99.3%
EBIT/Int Exp-4.1

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.